Respiratory syncytial virus Clinical Trials in Bangkok
3 recruitingBangkok, Thailand
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
RSV InfectionRespiratory Syncytial Virus (RSV)RSV
Enanta Pharmaceuticals, Inc150 enrolled8 locationsNCT07482657
Recruiting
Phase 2
Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV
Respiratory Syncytial Virus (RSV)
PENTA Foundation120 enrolled8 locationsNCT06873633
Recruiting
Phase 2
Assessing Antiviral Treatments in Early Symptomatic RSV
Respiratory Syncytial Virus, HumanRespiratory syncytial virus
University of Oxford1,000 enrolled2 locationsNCT06488300